Clinical Trial: Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis
Brief Summary: A multi center, randomized, double-blind, placebo-controlled, parallel, phase 2b clinical trial to evaluate the efficacy and safety of N02RS1 in patients with acute bronchitis
Detailed Summary: Suitable subjects randomized to the experimental or control group. The subjects eat IP during 7days. Visit 3(3 days) evaluate BSS through phone call and visit 4(8 days) evaluate efficacy and safety.
Sponsor: PharmaKing
Current Primary Outcome: BSS(Bronchitis Severity Score) score variation compared to baseline after 7 days [ Time Frame: Visit 1(-3days, screening), 2(0day, randomization), 3(3days), 4(8days) ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: PharmaKing
Dates:
Date Received: December 8, 2015
Date Started: December 2015
Date Completion:
Last Updated: March 29, 2016
Last Verified: March 2016